Vanguard Group’s TearLab Corporation TEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-51,802
Closed -$66K 4152
2017
Q3
$66K Sell
51,802
-2,730
-5% -$4.83K ﹤0.01% 4015
2017
Q2
$91K Sell
54,532
-21,458
-28% -$43.6K ﹤0.01% 3993
2017
Q1
$216K Buy
75,990
+2,239
+3% +$11.1K ﹤0.01% 3893
2016
Q4
$376K Sell
73,751
-8,700
-11% -$49.4K ﹤0.01% 3786
2016
Q3
$536K Sell
82,451
-147
-0.2% -$1.09K ﹤0.01% 3746
2016
Q2
$528K Buy
82,598
+310
+0.4% +$2.27K ﹤0.01% 3777
2016
Q1
$518K Buy
82,288
+100
+0.1% +$994 ﹤0.01% 3783
2015
Q4
$1.14M Buy
82,188
+690
+0.8% +$11.8K ﹤0.01% 3578
2015
Q3
$1.64M Buy
81,498
+518
+0.6% +$12.1K ﹤0.01% 3461
2015
Q2
$1.64M Buy
80,980
+2,561
+3% +$60.1K ﹤0.01% 3495
2015
Q1
$1.56M Hold
78,419
﹤0.01% 3494
2014
Q4
$2.08M Buy
78,419
+603
+0.8% +$16.6K ﹤0.01% 3276
2014
Q3
$2.65M Sell
77,816
-250
-0.3% -$10.6K ﹤0.01% 3147
2014
Q2
$3.8M Sell
78,066
-7,363
-9% -$359K ﹤0.01% 2983
2014
Q1
$5.78M Buy
85,429
+3,639
+4% +$279K ﹤0.01% 2752
2013
Q4
$7.64M Buy
81,790
+8,512
+12% +$848K ﹤0.01% 2574
2013
Q3
$8.1M Buy
73,278
+20,055
+38% +$2.5M ﹤0.01% 2495
2013
Q2
$5.65M Buy
+53,223
New +$4.87M ﹤0.01% 2596

Other funds holding TEAR

Vanguard Group's TEAR Position: Q4 2017 in Review

Vanguard Group sold out of TearLab Corporation (TEAR) in Q4 2017, closing a stake of 51,802 shares — an estimated $66K sold.

Vanguard Group first reported a position in TEAR in Q2 2013 and held it in 18 quarters. The position peaked at $8.1M in Q3 2013. 3 funds tracked by Wall St. Rank hold TEAR as of Q4 2017.

  • Vanguard Group reported no remaining TearLab Corporation position as of Q4 2017 after selling out during the quarter.
  • Vanguard Group sold 51,802 TearLab Corporation shares in Q4 2017, an estimated $66K.
  • Vanguard Group first reported a position in TearLab Corporation in Q2 2013 and held it in 18 quarters.
  • Vanguard Group's TearLab Corporation position peaked at $8.1M in Q3 2013.
  • 3 funds tracked by Wall St. Rank held TearLab Corporation as of Q4 2017.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.